Discovery and Engineering of Antibodies
MilleGen is a French Biotech company specialised in Antibody Discovery and Genetic Engineering of Antibodies.
MilleGen’s technology platform allows the selection of fully human antibodies from human monoclonal antibody libraries as well as antibody optimisation through a powerful DME (Directed Molecular Evolution) technology (MutaGen™). MilleGen's innovative DME platform, MutaGen™, combines random mutagenesis with a high throughput screening process and a bioinformatics analysis to improve antibodies for therapeutic and diagnostic use. Generated leads are ready to enter preclinical development.
Custom Services
MilleGen provides a know-how experience and expertise to research and industrial customers. The company offers an array of outsourcing options including High-Throughput DNA Sequencing, Bioinformatics, Peptides Synthesis and Antibodies Engineering & Production.
|
